rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-3-7
|
pubmed:abstractText |
Splenic irradiation is routinely used in the supportive treatment of lymphoepithelial and hemopoietic diseases associated with splenomegaly. A new short-time irradiation schedule with conventional dosage (Group A: 2 Gy/fract.) was compared retrospectively with low-dose prolonged treatment schedules (Group B: < or = 1 Gy/fract.) to establish its tolerance and its efficacy in terms of relieving splenomegaly-associated symptoms.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0378-584X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger GmbH, Freiburg
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12624513-Adult,
pubmed-meshheading:12624513-Aged,
pubmed-meshheading:12624513-Aged, 80 and over,
pubmed-meshheading:12624513-Blood Cell Count,
pubmed-meshheading:12624513-Dose Fractionation,
pubmed-meshheading:12624513-Female,
pubmed-meshheading:12624513-Humans,
pubmed-meshheading:12624513-Leukemia,
pubmed-meshheading:12624513-Lymphatic Irradiation,
pubmed-meshheading:12624513-Lymphoma, Non-Hodgkin,
pubmed-meshheading:12624513-Male,
pubmed-meshheading:12624513-Middle Aged,
pubmed-meshheading:12624513-Radiotherapy Dosage,
pubmed-meshheading:12624513-Retrospective Studies,
pubmed-meshheading:12624513-Splenomegaly,
pubmed-meshheading:12624513-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Short-time splenic irradiation for splenomegaly.
|
pubmed:affiliation |
Institute of Radio-Oncology, Kaiser-Franz-Josef Hospital, Vienna, Austria. annemarie.schratter@kfj.magwien.gv.at
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|